Saylo Construction

Nam augue velit, fermentum sed erat non, efficitur interdum lectus. Donec hendrerit lorem a dui euismod tempus. Vivamus auctor blandit tellus et interdum.

Get In Touch
image
01 Mar

Oragenics Announces Closing of Public Offering

Read More
image
28 Feb

Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock

Read More
image
09 Feb

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 million

Read More
image
07 Feb

Perfect Moment Announces Pricing of Initial Public Offering

Read More
image
12 Dec

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

Read More
image
05 Dec

Laidlaw served as Co-Manager on the $129,000,000 Common Stock and Concurrent Private Placement for Soleno Therapeutics (SLNO)

Read More
© 2024 Copyright Laidlaw & Company (UK) Ltd. – All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through StoneX, a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).